Home / Publications / Foreign investments in German life science companies...

Foreign investments in German life science companies become subject to mandatory notification

22/05/2020

In response to the COVID-19 pandemic, Germany has widened the scope of its investment control to include numerous life science companies. The amendments to the Foreign Trade and Payments Ordinance ("AWV") were published on 20th May 2020 and will enter into force...

Read more

Authors

Portrait ofKai Neuhaus
Kai Neuhaus, LL.M.
Partner
Brussels - EU Law Office
Portrait ofMoritz Pottek
Moritz Pottek
Counsel
Brussels - EU Law Office